Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Cysteine-rich Whey Protein Isolate (Immunocal®) in Post COVID-19 Cognitive Impairment

NCT07184398 is registered in ClinicalTrials.gov with Universidad Libre seccional Cali as lead sponsor.

NCT NCT07184398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07184398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Cysteine-rich Whey Protein Isolate (Immunocal®) in Post COVID-19 Cognitive Impairment
Lead sponsor
Universidad Libre seccional Cali
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2024
Completion date
January 1, 2025
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 (sars-cov-2 infection)